Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Targeted cancer therapies often cause serious skin problems that need careful management.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Different rheumatological diseases can cause specific skin problems.

The document suggests a possible connection between rapid weight loss and hair loss, and reports a case of skin condition improvement after stopping acne medication.

Most pediatric cancer patients in the study developed skin problems, often due to their cancer treatment.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Acneiform follicular mucinosis can be controlled with systemic corticosteroids.

Topical human epidermal growth factor may effectively treat acne caused by cancer medication.

Intermittent isotretinoin can cause various skin, hair, and nail changes.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

Chronic cutaneous lupus erythematosus should be considered when acne treatments don't work.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Non-ablative fractional laser treatments have a low risk of side effects in Asian patients.

Isotretinoin effectively treated severe acne in HIV-positive women, with improved skin and CD4 counts, but some experienced side effects like skin dryness and hair loss.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

The study evaluated how alopecia areata severity relates to its psychosocial effects on patients.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Minoxidil, a hair loss treatment, may cause acne-like skin eruptions.

EGFR inhibitors can cause yellowish skin eruptions.